In compliance with Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, Welcure Drugs & Pharmaceuticals has informed about meeting of Board of Directors of the Company is scheduled to be held on Monday, 15th January, 2018, to consider un-audited financial results for the quarter ended on 31.12.2018.
The above information is a part of company’s filings submitted to BSE.